Literature DB >> 15717285

Fine mapping of chromosome 17 translocation breakpoints > or = 900 Kb upstream of SOX9 in acampomelic campomelic dysplasia and a mild, familial skeletal dysplasia.

Katherine L Hill-Harfe1, Lee Kaplan, Heather J Stalker, Roberto T Zori, Ramona Pop, Gerd Scherer, Margaret R Wallace.   

Abstract

Previously, our group reported a five-generation family in which a balanced t(13;17) translocation is associated with a spectrum of skeletal abnormalities, including Robin sequence, hypoplastic scapulae, and a missing pair of ribs. Using polymerase chain reaction (PCR) with chromosome-specific markers to analyze DBA from somatic cell hybrids containing the derivative translocation chromosomes, we narrowed the breakpoint on each chromosome. Subsequent sequencing of PCR products spanning the breakpoints identified the breaks precisely. The chromosome 17 breakpoint maps approximately 932 kb upstream of the sex-determining region Y (SRY)-related high-mobility group box gene (SOX) within a noncoding transcript represented by two IMAGE cDNA clones. A growing number of reports have implicated chromosome 17 breakpoints at a distance of up to 1 Mb from SOX9 in some cases of campomelic dysplasia (CD). Although this multigeneration family has a disorder that shares some features with CD, their phenotype is significantly milder than any reported cases of (nonmosaic) CD. Therefore, this case may represent an etiologically distinct skeletal dysplasia or may be an extremely mild familial example of CD, caused by the most proximal translocation breakpoint from SOX9 reported to date. In addition, we have refined the breakpoint in a acampomelic CD case described elsewhere and have found that it lies approximately 900 kb upstream of SOX9.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717285      PMCID: PMC1199303          DOI: 10.1086/429254

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  53 in total

1.  Campomelic dysplasia associated with a de novo 2q;17q reciprocal translocation.

Authors:  I D Young; J M Zuccollo; E L Maltby; N J Broderick
Journal:  J Med Genet       Date:  1992-04       Impact factor: 6.318

2.  Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4.

Authors:  Y J de Kok; E R Vossenaar; C W Cremers; N Dahl; J Laporte; L J Hu; D Lacombe; N Fischel-Ghodsian; R A Friedman; L S Parnes; P Thorpe; M Bitner-Glindzicz; H J Pander; H Heilbronner; J Graveline; J T den Dunnen; H G Brunner; H H Ropers; F P Cremers
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

3.  Isolation of a testis-specific cDNA on chromosome 17q from a region adjacent to the breakpoint of t(12;17) observed in a patient with acampomelic campomelic dysplasia and sex reversal.

Authors:  S Ninomiya; M Isomura; K Narahara; Y Seino; Y Nakamura
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

4.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene.

Authors:  J W Foster; M A Dominguez-Steglich; S Guioli; C Kwok; P A Weller; M Stevanović; J Weissenbach; S Mansour; I D Young; P N Goodfellow
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

5.  Campomelic dysplasia: evidence of autosomal dominant inheritance.

Authors:  S A Lynch; M L Gaunt; A M Minford
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

6.  Translocation breakpoints in three patients with campomelic dysplasia and autosomal sex reversal map more than 130 kb from SOX9.

Authors:  J Wirth; T Wagner; J Meyer; R A Pfeiffer; H U Tietze; W Schempp; G Scherer
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

7.  A clinical and genetic study of campomelic dysplasia.

Authors:  S Mansour; C M Hall; M E Pembrey; I D Young
Journal:  J Med Genet       Date:  1995-06       Impact factor: 6.318

8.  Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9.

Authors:  T Wagner; J Wirth; J Meyer; B Zabel; M Held; J Zimmer; J Pasantes; F D Bricarelli; J Keutel; E Hustert; U Wolf; N Tommerup; W Schempp; G Scherer
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

Review 9.  Acampomelic campomelic syndrome and sex reversal associated with de novo t(12;17) translocation.

Authors:  S Ninomiya; K Narahara; K Tsuji; Y Yokoyama; S Ito; Y Seino
Journal:  Am J Med Genet       Date:  1995-03-13

10.  Mutations in SOX9, the gene responsible for Campomelic dysplasia and autosomal sex reversal.

Authors:  C Kwok; P A Weller; S Guioli; J W Foster; S Mansour; O Zuffardi; H H Punnett; M A Dominguez-Steglich; J D Brook; I D Young
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

View more
  16 in total

1.  Chromosome conformation capture-on-chip analysis of long-range cis-interactions of the SOX9 promoter.

Authors:  Marta Smyk; Przemyslaw Szafranski; Michał Startek; Anna Gambin; Paweł Stankiewicz
Journal:  Chromosome Res       Date:  2013-11-20       Impact factor: 5.239

2.  SOX9 chromatin folding domains correlate with its real and putative distant cis-regulatory elements.

Authors:  Marta Smyk; Kadir Caner Akdemir; Paweł Stankiewicz
Journal:  Nucleus       Date:  2017-01-13       Impact factor: 4.197

3.  Clinical Utility Gene Card for: campomelic dysplasia.

Authors:  Gerd Scherer; Bernhard Zabel; Gen Nishimura
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

4.  Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia.

Authors:  Gopalrao V N Velagaleti; Gabriel A Bien-Willner; Jill K Northup; Lillian H Lockhart; Judy C Hawkins; Syed M Jalal; Marjorie Withers; James R Lupski; Pawel Stankiewicz
Journal:  Am J Hum Genet       Date:  2005-02-22       Impact factor: 11.025

Review 5.  Disruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences.

Authors:  Shipra Bhatia; Dirk A Kleinjan
Journal:  Hum Genet       Date:  2014-02-05       Impact factor: 4.132

6.  Mild Campomelic Dysplasia: Report on a Case and Review.

Authors:  S Corbani; E Chouery; B Eid; N Jalkh; J Abou Ghoch; A Mégarbané
Journal:  Mol Syndromol       Date:  2011-01-10

Review 7.  Human Structural Variation: Mechanisms of Chromosome Rearrangements.

Authors:  Brooke Weckselblatt; M Katharine Rudd
Journal:  Trends Genet       Date:  2015-07-22       Impact factor: 11.639

8.  Pierre Robin sequence may be caused by dysregulation of SOX9 and KCNJ2.

Authors:  Linda P Jakobsen; Reinhard Ullmann; Steen B Christensen; Karl Erik Jensen; Kirsten Mølsted; Karen F Henriksen; Claus Hansen; Mary A Knudsen; Lars A Larsen; Niels Tommerup; Zeynep Tümer
Journal:  J Med Genet       Date:  2007-06       Impact factor: 6.318

9.  Testis development in the absence of SRY: chromosomal rearrangements at SOX9 and SOX3.

Authors:  Annalisa Vetro; Mohammad Reza Dehghani; Lilia Kraoua; Roberto Giorda; Silvana Beri; Laura Cardarelli; Maurizio Merico; Emmanouil Manolakos; Alexis Parada-Bustamante; Andrea Castro; Orietta Radi; Giovanna Camerino; Alfredo Brusco; Marjan Sabaghian; Crystalena Sofocleous; Francesca Forzano; Pietro Palumbo; Orazio Palumbo; Savino Calvano; Leopoldo Zelante; Paola Grammatico; Sabrina Giglio; Mohamed Basly; Myriam Chaabouni; Massimo Carella; Gianni Russo; Maria Clara Bonaglia; Orsetta Zuffardi
Journal:  Eur J Hum Genet       Date:  2014-11-05       Impact factor: 4.246

10.  Identification of novel craniofacial regulatory domains located far upstream of SOX9 and disrupted in Pierre Robin sequence.

Authors:  Christopher T Gordon; Catia Attanasio; Shipra Bhatia; Sabina Benko; Morad Ansari; Tiong Y Tan; Arnold Munnich; Len A Pennacchio; Véronique Abadie; I Karen Temple; Alice Goldenberg; Veronica van Heyningen; Jeanne Amiel; David FitzPatrick; Dirk A Kleinjan; Axel Visel; Stanislas Lyonnet
Journal:  Hum Mutat       Date:  2014-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.